UK pharmaceutical giant GSK says it will pay as much as $2.2bn (£1.68bn) to settle thousands of cases in US courts over claims that a discontinued version of its heartburn drug Zantac caused cancer.

GSK shares jumped as much as 6.5% on Thursday after the British drugmaker struck a $2.2 billion settlement over U.S. lawsuits that alleged its discontinued heartburn drug Zantac caused cancer.

Tens of thousands of Americans are in line to share $2.2bn (£1.7bn) after GSK agreed a settlement over claims its indigestion drug caused cancers. The British drug giant has agreed to pay up to $2.2bn ...

It follows concern in several countries over the presence of impurities in Zantac and other ranitidine products. Canada and France have already announced Zantac recalls. The US and the European ...

Heritage Pharmaceuticals and Apotex will pay $49.1 million in a settlement with Pennsylvania, New Jersey and other states.

GSK announced that it agreed to settle these suits for up to $2.2 billion, in a press release on Wednesday. GSK says that ...

Prolonged Q-T interval Hospitalization 80 (07/09/2001, occurred 9/27/1991) 37, M Droperidol 125 mg, ranitidine, clomeiethiazole, nifedipine, metoprolol, potassium chloride Ventricular fibrillation ...

MEGAN McKenna has opened up about the challenges of motherhood after her newborn son, Landon, received a painful medical diagnosis. The former Towie star revealed the toll it has taken on her ...

Background Medical management of GERD mainly uses proton pump inhibitors. Alginates also have proven efficacy. The aim of this trial was to compare short-term efficacy of an alginate (Gaviscon ...